Galmed Pharmaceuticals Ltd's activity chart (see below) currently has 11 price targets and 23 ratings on display.
Analysts' price targets on this stock were met 46.67% of the time, taking 604 days on average.
Most recent stock forecast was given by JASON MCCARTHY from MAXIM GROUP on 24-Jul-2023. First documented stock forecast 28-Mar-2016.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 24-Jul-2023
3 years 3 months 29 days ago
(24-Jul-2023)
1/3 (33.33%)
$2383.2 (96.22%)
89
Buy Since 12-Jun-2018
$180
4 years 3 months 14 days ago
(08-Aug-2022)
0/2 (0%)
$98.89 (121.92%)
Hold Since 18-May-2022
4 years 6 months 4 days ago
(18-May-2022)
1/2 (50%)
$4573.8 (144.46%)
2101
Buy Since 13-Jul-2018
$375
6 years 6 months 8 days ago
(14-May-2020)
1/2 (50%)
$-539.4 (-58.99%)
581
Buy Since 24-Mar-2017
8 years 8 months 7 days ago
(15-Mar-2018)
2/2 (100%)
$1251 (98.58%)
249
What is GLMD (Galmed Pharmaceuticals Ltd) average time for price targets to be met?
Which analyst most recently updated their price target on GLMD (Galmed Pharmaceuticals Ltd)?
Which analyst has the lowest performance score on GLMD (Galmed Pharmaceuticals Ltd) with a proven track record?
Which analyst has the most public recommendations on GLMD (Galmed Pharmaceuticals Ltd)?
Which analyst is the currently most bullish on GLMD (Galmed Pharmaceuticals Ltd)?
Which analyst is the currently most reserved on GLMD (Galmed Pharmaceuticals Ltd)?